References
- Abrishami M, Tohidinezhad F, Daneshvar R, et al. Ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran. Ocul Immunol Inflamm. 2020;28(5):739–744. doi:https://doi.org/10.1080/09273948.2020.1773868.
- Nazemipour M, Shakiba M, Mansournia MA. Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran [published online ahead of print, 2021 Feb 15]. Lancet Infect Dis. 2021;S1473-3099(21)00044-X. doi:https://doi.org/10.1016/S1473-3099(21)00044-X.
- Poustchi H, Darvishian M, Mohammadi Z, et al. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study [published online ahead of print, 2020 Dec 15]. Lancet Infect Dis. 2020;S1473-3099(20)30858–6. doi:https://doi.org/10.1016/S1473-3099(20)30858-6.
- Kaya H, Çalışkan A, Okul M, Sarı T, Akbudak İH. Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients. J Infect Dev Countries. 2020;14(9):977–981. doi:https://doi.org/10.3855/jidc.13224.
- Li X, Chan JF, Li KK, et al. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms [published online ahead of print, 2020 Sep 17]. Infection. 2020;1–9.
- Casagrande M, Fitzek A, Puschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020:1–5. doi:https://doi.org/10.1080/09273948.2020.1746355.
- Choudhary R, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2017;29(1):7–16. doi:https://doi.org/10.1016/j.joco.2016.09.009.
- Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179–2184. doi:https://doi.org/10.1007/s00415-020-09929-7.
- Lu CW, Liu XF, Jia ZF. 2019‑nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395:E39. doi:https://doi.org/10.1016/S0140-6736(20)30313-5.
- Güemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B, et al. Novel insights into the transmission of SARS-CoV-2 through the ocular surface and its detection in tears and conjunctival secretions: a review. Adv Ther. 2020;37(10):4086–4095. doi:https://doi.org/10.1007/s12325-020-01442-7.
- Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID‑19). Can J Ophthalmol. 2020;55:e125‑9. doi:https://doi.org/10.1016/j.jcjo.2020.03.003.
- Casalino G, Monaco G, Di Sarro PP, David A, Scialdone A. Coronavirus disease 2019 presenting with conjunctivitis as the first symptom. Eye (Lond). 2020;34(7):1235–1236. doi:https://doi.org/10.1038/s41433-020-0909-x.
- Soares RPDS, Fernandes APNL, Botarelli FR, Araújo JNM, Olímpio JA, Vitor AF. Clinical indicators of dry eye severity nursing outcome in intensive care unit. Rev Lat Am Enfermagem. 2019;27:e3201. doi:https://doi.org/10.1590/1518-8345.2983.3201.
- Simkiene J, Pranskuniene Z, Vitkauskiene A, Pilvinis V, Boerma EC, Pranskunas A. Ocular microvascular changes in patients with sepsis: a prospective observational study. Ann Intensive Care. 2020;10(1):38. doi:https://doi.org/10.1186/s13613-020-00655-x.